AstraZeneca stock price increase by over 20% by May 2025? | Binary | | | 7 months ago | |
AstraZeneca achieves $40 billion revenue by 2025? | Binary | | | 7 months ago | |
Leading AstraZeneca revenue growth portfolio by 2025 | Categorical | | | 7 months ago | |
AstraZeneca releases 10 new medicines by 2025? | Binary | | | 7 months ago | |
Pascal Soriot remains CEO of AstraZeneca through 2025? | Binary | | | 7 months ago | |
AstraZeneca oncology double-digit growth by 2025? | Binary | | | 7 months ago | |
AstraZeneca Revenue Milestone by 2025 | Categorical | | | 7 months ago | |
Highest Growth Division of AstraZeneca by 2025 | Categorical | | | 7 months ago | |
Will Pfizer appeal the overturned $107.5 million verdict by AstraZeneca by December 31, 2024? | Binary | | | 4 months ago | |
Who will be AstraZeneca's CEO by the end of 2024? | Categorical | | | 4 months ago | |
Will AstraZeneca face another patent lawsuit from Pfizer by the end of 2024? | Binary | | | 4 months ago | |
AstraZeneca releases new medicines progress report by 2024? | Binary | | | 7 months ago | |
Number of AstraZeneca new medicines approved by 2025 | Categorical | | | 7 months ago | |
Number of New Medicines Launched by AstraZeneca by 2025 | Categorical | | | 7 months ago | |
Will AstraZeneca's stock price increase by more than 10% by the end of 2024? | Binary | | | 4 months ago | |
CEO Pascal Soriot's status with AstraZeneca by 2025 | Categorical | | | 7 months ago | |
What will be the outcome of any potential appeal by Pfizer regarding the overturned $107.5 million verdict by December 31, 2024? | Categorical | | | 4 months ago | |
Which company will have the highest market cap by the end of 2024? | Categorical | | | 4 months ago | |
